financetom
Business
financetom
/
Business
/
Machinery Stocks Are Up Today: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Machinery Stocks Are Up Today: What's Going On?
Apr 9, 2025 2:52 PM

Machinery shares such as Arcosa Inc. ( ACA ) and Valmont Industries Inc. ( VMI ) are trading higher Wednesday on news that President Donald Trump would pause tariffs for most U.S. trading partners.

What To Know: The gains followed a surprise announcement from Trump of a 90-day suspension on reciprocal tariffs for all countries that have not retaliated against previous U.S. trade measures. The move excludes China, which instead will face a sharp increase in tariffs.

Trump’s decision to reward non-retaliatory nations with a temporary 10% tariff and delay further duties appears to have eased investor fears around escalating trade tensions.

In contrast, Trump sharply criticized China in a Truth Social post, accusing it of exploiting the U.S. and pledging a new 125% tariff on Chinese imports. He stated that over 75 countries had refrained from retaliating and would benefit from the pause.

At a White House press conference, Treasury Secretary Scott Bessent emphasized that the changes reflect an attempt to address long-standing global trade imbalances. He noted that markets previously misunderstood the scale of Trump’s trade measures and described the 10% reciprocal tariff as a temporary floor that adds clarity going forward.

Bessent also accused Beijing of exacerbating the trade deficit and portraying itself as an uncooperative actor in global trade. He suggested that the new policy would give the U.S. greater leverage to force changes in its trade relationship with China.

Price Action: Arcosa ( ACA ) shares closed Wednesday up 10.67% to $78.20 and Valmont Industries ( VMI ) shares are up 7.65% to $284.96, according to Benzinga Pro.

Read Next:

• Wall Street Roars As Trump Pauses Tariffs For Non-Retaliator, Hikes China Duties To 125%

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Manus AI announces partnership with Alibaba's Qwen team
China's Manus AI announces partnership with Alibaba's Qwen team
Mar 11, 2025
BEIJING, March 11 (Reuters) - Chinese artificial intelligence start-up Manus AI announced on Tuesday a strategic partnership with the team behind Alibaba's ( BABA ) Qwen AI models. The two sides will collaborate based on Qwen's open-source AI models and aim to implement all of Manus' functionalities on China's domestic models and computing platforms, Manus co-founder Zhang Tao said on...
UK's Thames Water rescue plan faces creditor-group appeal
UK's Thames Water rescue plan faces creditor-group appeal
Mar 11, 2025
LONDON, March 11 (Reuters) - Thames Water, Britain's biggest water supplier, faced another court battle on Tuesday as a group of its junior creditors started a legal challenge over a 3 billion pound ($3.9 billion) debt lifeline necessary to keep it afloat. The company is at the centre of a public backlash against the water industry. Mismanagement of Thames Water...
Embraer eyes potential KC-390 final assembly line in Poland
Embraer eyes potential KC-390 final assembly line in Poland
Mar 11, 2025
SAO PAULO (Reuters) - Brazilian planemaker Embraer is considering establishing a final assembly line for its KC-390 military cargo aircraft in Poland, it said on Tuesday amid strong sales momentum for the plane in Europe. Embraer is looking at partners for parts manufacturing and for a potential final assembly line for the KC-390, the firm said in a statement as...
Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program
Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program
Mar 11, 2025
08:25 AM EDT, 03/11/2025 (MT Newswires) -- Viking Therapeutics ( VKTX ) said Tuesday it has signed a deal with CordenPharma to manufacture and supply both the active pharmaceutical ingredient and finished product for Viking's VK2735 program for obesity. Under the terms of the deal, Viking said it will pay $150 million between 2025 and 2028 to CordenPharma, which has...
Copyright 2023-2026 - www.financetom.com All Rights Reserved